Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634283 · ClinicalTrials.gov registry record · Phase 4
Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT00634283 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 6 participants.
The verdict
NCT00634283, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study examines the effects of an antidepressant medication and placebo on the brain functioning of normal subjects. In this study, recordings of brain electrical activity are being used to detect and monitor the response to treatment with venlafaxine IR (Effexor), a drug used for the treatment of depression. The intent of this study is to test specific hypotheses regarding: 1. long-term brain effects of a single course of antidepressant treatment 2. pharmaco-conditioning effects underlying antidepressant tolerance/sensitization 3. brain functional response to initial versus subsequent antidepressant trials in normal healthy subjects.
Interventions
- DRUG venlafaxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00634283
The ClinicalTrials.gov registry entry for NCT00634283 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which venlafaxine is the first listed.
NCT00634283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00634283 about?
NCT00634283 is a clinical study titled "Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects". This study examines the effects of an antidepressant medication and placebo on the brain functioning of normal subjects. In this study, recordings of brain electrical activity are being used to detect and monitor the response to treatment with venlafaxine IR (Effexor), a drug used for the treatment ...
What is the current status of trial NCT00634283?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2008-02. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00634283?
The interventions under investigation include: venlafaxine (DRUG).
Who is sponsoring clinical trial NCT00634283?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.